Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 2,390 shares at $31.15 ($74K) on 2019-01-30, disclosed to the SEC on 2019-01-30.
Open-market sale of $74k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PAHC | SELL | 2019-01-24 | $60K | — | Filing → |
| PAHC | SELL | 2019-01-24 | $237K | — | Filing → |
| PAHC | SELL | 2019-01-18 | $242K | — | Filing → |